Medical Device/ Diagnostic
FloBio is a Philadelphia-based medical diagnostics company with the mission of saving lives by bringing precision diagnostics to hemostasis testing. FloBio’s vision is to provide clinicians with rapid, actionable information that enables optimal decision-making and cost-effective management of blood clotting abnormalities and serious bleeding. It is developing a novel point-of-care IVD platform with its first DOAC test granted Breakthrough Device Designation by the US Food & Drug Administration. FloBio was formed in 2017 after spinning out from the University of Pennsylvania.